Large Cell Lung Carcinoma Terminated Phase 2 Trials for Carboplatin (DB00958)

Also known as: Carcinoma, Large Cell Lung

IndicationStatusPhase
DBCOND0044133 (Large Cell Lung Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00955305Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerTreatment